Cedrus »

Vertex Pharmaceuticals Incorporated shares owned by Cedrus

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cedrus from 13F filings

Historical chart of Cedrus investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Cedrus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cedrus

Quarter filed Position value Share count Share price at filing
2024-03-31 $291k 696 418.01
2023-12-31 $322k 791 406.89

More positions owned by Cedrus

Vanguard Index Fds Growth Etf (VUG)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
First Tr Exchange-traded Ft Vest Ris (RDVI)
First Tr Exchng Traded Fd Vi Low Dur Strtgc (LDSF)
Wisdomtree Tr Glb Us Qtly Div (DNL)
Vanguard World Mega Cap Val Etf (MGV)
Ishares Tr MRGSTR MD CP GRW (IMCG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Value Etf (VTV)
Pacer Fds Tr Pacer Us Small (CALF)
Ishares Tr 10-20 Yr Trs Etf (TLH)

View all positions for Cedrus

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated